Evidence map›Paper›PMID 34021080›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Inoculum effect of antimicrobial peptides.

Maria Rosa Loffredo, Filippo Savini, Sara Bobone, Bruno Casciaro, Henrik Franzyk, Maria Luisa Mangoni, Lorenzo Stella

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Probing theRSC chemical biology · 2026
    Article
  3. Pharmacokinetics determine persister formation inJAC-antimicrobial resistance · 2026
    Article
  4. Article
  5. Synergistic Action of Antimicrobial Peptides and Antibiotics.International journal of molecular sciences · 2026
    Review
  6. Antibacterial Potential ofFoods (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Lack of Spontaneous and Adaptive Resistance Development inAntibiotics (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Perturbation-specific transcriptional mapping for unbiased target elucidation of antibiotics.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Rosa LoffredoLaboratory affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-5040-5688
Filippo SaviniDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-7680-9242
Sara BoboneDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-7975-3803
Bruno CasciaroCenter for Life Nano- & Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy.ORCID 0000-0003-1295-1084
Henrik FranzykDepartment of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen, Denmark.ORCID 0000-0002-2822-1927
Maria Luisa MangoniLaboratory affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy; marialuisa.mangoni@uniroma1.it stella@stc.uniroma2.it.ORCID 0000-0002-5991-5868
Lorenzo StellaDepartment of Chemical Science and Technologies, University of Rome Tor Vergata, 00133 Rome, Italy; marialuisa.mangoni@uniroma1.it stella@stc.uniroma2.it.ORCID 0000-0002-5489-7381

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The activity of many antibiotics depends on the initial density of cells used in bacterial growth inhibition assays. This phenomenon, termed the inoculum effect, can have important consequences for the therapeutic efficacy of the drugs, because bacterial loads vary by several orders of magnitude in clinically relevant infections. Antimicrobial peptides are a promising class of molecules in the fight against drug-resistant bacteria because they act mainly by perturbing the cell membranes rather than by inhibiting intracellular targets. Here, we report a systematic characterization of the inoculum effect for this class of antibacterial compounds. Minimum inhibitory concentration values were measured for 13 peptides (including all-D enantiomers) and peptidomimetics, covering more than seven orders of magnitude in inoculated cell density. In most cases, the inoculum effect was significant for cell densities above the standard inoculum of 5 × 10

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesBacteriaBacterial InfectionsBacterial LoadCell MembraneDrug SynergismHumansMicrobial Sensitivity TestsPeptidomimeticsStaphylococcus aureusStereoisomerismAnti-Bacterial AgentsAntimicrobial PeptidesPeptidomimeticsantimicrobial activityantimicrobial peptidesinoculum effect

Identifiers

PMID34021080
PMCPMC8166072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.